The objectives of this project are to demonstrate that 1) intravenous magnesium is beneficial in acute ischemic stroke as evidenced by decrease in the growth of infarct volume over time as measured by diffusion weighted magnetic resonance imaging (DWI); 2) DWI is a valuable surrogate outcome measure in acute ischemic stroke clinical trials; 3) diffusion/perfusion mismatch is a useful entry criterion for neuroprotective treatment in acute stroke clinical trials; and 4) intravenous magnesium is safe and potentially beneficial in intracerebral hemorrhage. During the first phase of the project, objectives 1-3 will be assessed by conducting a randomized, double-blind, placebo controlled trial to evaluate the efficacy of intravenous magnesium as a neuroprotective agent in acute ischemic stroke. The trial will use diffusion/perfusion magnetic resonance imaging as a surrogate outcome marker. 150 patients will be enrolled within 12 hours of symptom onset at 3 UCLA-associated hospitals. The second phase of this project will be a parallel pilot randomized, double-blind, placebo-controlled trial to evaluate the safety and explore the efficacy of intravenous magnesium in acute intracerebral hemorrhage, enrolling 40 patients. Additional data will be collected to assess the diffusion/perfusion MR signature of acute intracerebral hemorrhage. The findings of this project will have direct relevance to future treatment of acute ischemic and hemorrhagic stroke as well as to the design of future trials of neuroprotective agents. The results will help establish the utility of novel diffusion/perfusion MR techniques as demonstrating physiologic, objective changes that can be used as entry and outcome criteria in evaluating stroke patients. During the award period, in addition to serving as the principal investigator of these trials, Dr. Kidwell will pursue in-depth didactic multidisciplinary training in biostatistics, epidemiology, clinimetrics and magnetic resonance radiology. She will be mentored by Drs. Jeffrey Saver, Sidney Starkman, Jeffry Alger, and Barbara Vickrey. At the completion of this training, Dr. Kidwell will have acquired all requisite experience and skills to function as an independent investigator in clinical studies of novel magnetic resonance stroke imaging techniques, pivotal trials of promising therapeutic agents, and studies of the pathophysiology of acute human cerebral ischemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23NS002088-05
Application #
6606921
Study Section
NST-2 Subcommittee (NST)
Program Officer
Conwit, Robin
Project Start
1999-04-02
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2005-03-31
Support Year
5
Fiscal Year
2003
Total Cost
$121,770
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kidwell, Chelsea S; Lees, Kennedy R; Muir, Keith W et al. (2009) Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke 40:1704-9
Kidwell, Chelsea S; Latour, Larry; Saver, Jeffrey L et al. (2008) Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis 25:338-43
Rajajee, Venkatakrishna; Kidwell, Chelsea; Starkman, Sidney et al. (2008) Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI. J Neuroimaging 18:66-72
Kim, D; Ford, G A; Kidwell, C S et al. (2007) Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol 28:159-63
Rajajee, V; Kidwell, C; Starkman, S et al. (2006) Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 67:980-4
Liebeskind, David S; Kidwell, Chelsea S; Sayre, James W et al. (2006) Evidence of publication bias in reporting acute stroke clinical trials. Neurology 67:973-9
Liebeskind, David S; Kidwell, Chelsea S; UCLA Thrombolysis Investigators (2005) Advanced MR imaging of acute stroke: the University of California at Los Angeles endovascular therapy experience. Neuroimaging Clin N Am 15:455-66, xiii
Ovbiagele, Bruce; Saver, Jeffrey L; Fredieu, Andre et al. (2004) In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 35:2879-83
Ovbiagele, B; Saver, J L; Fredieu, A et al. (2004) PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 63:1217-22
Ostrem, Jill L; Saver, Jeffrey L; Alger, Jeffry R et al. (2004) Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 35:e30-4

Showing the most recent 10 out of 22 publications